NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...

After BioNTech’s acquisition of CureVac closes, BioNTech will pay GSK another $130 million and a 1% royalty on rest-of-world ...

HHS officials are citing an extensive list of studies purported to document harms caused by mRNA vaccines as scientific ...

The Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Foundation, has launched ...

The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...

The government’s cancellation of almost $500 million in contracts involving mRNA vaccines could halt progress on cancer ...

"People are going to die because we're cutting short funding for this technology," Dr. Jerome Adams said in an interview with ...

The U.S. Department of Health and Human Services announced on Tuesday that it will cancel $500 million worth of projects ...

President Trump’s laissez-faire approach is notable, given that the development of the Covid vaccine was seen as one of his ...

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...

New messenger RNA vaccines to fight the coronavirus are based on a technology that could transform medicine. Next up: sickle cell and HIV. On December 23, as part of a publicity push to encourage ...